Virax Biolabs Group Ltd. Class A had a revenue of 79.92K in the quarter ending Mar 31, 2024, with 4.47%. This bring the company's revenue in the last twelve months to 156.42K, Decreased 104.47%. In the fiscal year ending Mar 31, 2024, Virax Biolabs Group Ltd. Class A had annual revenue of 156.42K with ― growth.